235 related articles for article (PubMed ID: 11314681)
1. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
2. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
[TBL] [Abstract][Full Text] [Related]
3. Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers.
Iudice A; Bonanni E; Maestri M; Nucciarone B; Brotini S; Manca L; Iudice G; Murri L
Int J Clin Pharmacol Ther; 2002 Jul; 40(7):304-9. PubMed ID: 12139207
[TBL] [Abstract][Full Text] [Related]
4. Ritanserin improves sleep quality in narcolepsy.
Mayer G
Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.
Idzikowski C; Mills FJ; Glennard R
Brain Res; 1986 Jul; 378(1):164-8. PubMed ID: 3091188
[TBL] [Abstract][Full Text] [Related]
6. Ritanserin-induced changes in sleep-waking phases in rats.
Kirov R; Moyanova S
Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
[TBL] [Abstract][Full Text] [Related]
7. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT2 antagonist ritanserin decreases sleep in cats.
Sommerfelt L; Ursin R
Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.
Brandenberger G; Luthringer R; Muller G; Gronfier C; Schaltenbrand N; Macher JP; Muzet A; Follenius M
J Endocrinol Invest; 1996 Sep; 19(8):556-62. PubMed ID: 8905480
[TBL] [Abstract][Full Text] [Related]
10. Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.
Welsh SE; Romano AG; Harvey JA
Psychopharmacology (Berl); 1998 May; 137(2):157-63. PubMed ID: 9630002
[TBL] [Abstract][Full Text] [Related]
11. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
[TBL] [Abstract][Full Text] [Related]
12. Age-related effect of ritanserin on the sleep-waking phases in rats.
Kirov R; Moyanova S
Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
[TBL] [Abstract][Full Text] [Related]
13. Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship.
Johnson LC; Spinweber CL; Gomez SA; Matteson LT
Sleep; 1990 Apr; 13(2):121-35. PubMed ID: 2184488
[TBL] [Abstract][Full Text] [Related]
14. Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers.
Wilson SJ; Bailey JE; Alford C; Nutt DJ
J Psychopharmacol; 2000; 14(4):378-86. PubMed ID: 11198056
[TBL] [Abstract][Full Text] [Related]
15. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
Silhol S; Glin L; Gottesmann C
Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2 receptor antagonism and slow-wave sleep in major depression.
Staner L; Kempenaers C; Simonnet MP; Fransolet L; Mendlewicz J
Acta Psychiatr Scand; 1992 Aug; 86(2):133-7. PubMed ID: 1529736
[TBL] [Abstract][Full Text] [Related]
17. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
[TBL] [Abstract][Full Text] [Related]
18. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Costall B; Naylor RJ
Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
[TBL] [Abstract][Full Text] [Related]
19. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
Loas G
Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
[TBL] [Abstract][Full Text] [Related]
20. Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.
da Roza Davis JM; Sharpley AL; Cowen PJ
Psychopharmacology (Berl); 1992; 108(3):387-9. PubMed ID: 1523288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
